Compared to the early reduction group , the temporary reduction group exhibited higher baseline depression ( p < 0.01 ) and anxiety ( p < 0.01 ) , but did not differ in treatment received , with both groups attending significantly more cessation visits ( p < 0.001 ) and more likely to receive recommended pharmacotherapy ( p < 0.001 ) than the no reduction group between baseline and 6months .